AstraZeneca gets FDA ok for lymphocytic leukemia drug
AstraZeneca announced that the U.S. FDA has approved Calquence for adult patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Lymphoma | Pharmaceuticals